Author:
Tsukuda M, ,Kida A,Fujii M,Kono N,Yoshihara T,Hasegawa Y,Sugita M
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Akasu T, Moriya Y, Yoshida S, Shirao K, Ohashi Y, Kodaira S, NSAS-CC Group (2004) Adjuvant oral and tegafur (UFT) improves survival after complete mesorectal excision (ME) for pathologic TNM stage III rectal cancer (RC): results of the national surgical adjuvant study (NSAS)-colorectal cancer (CC) 01 randomized trial. Proc Am Soc Clin Oncol 23: 251 (Abstr. 3524)
2. Argiris A, Brockstein BE, Haraf DJ, Stenson KM, Mittal BB, Kies MS, Rosen FR, Javanovic B, Vokes EE (2004) Competing of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin Cancer Res 10: 1956–1962
3. Brockstein B, Haraf DJ, Rademaker AW, Kies MS, Stenson KM, Rosen F, Mittal BB, Pelzer H, Fung BB, Witt ME, Wenig B, Portugal L, Weichselbaum RW, Vokes EE (2004) Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol 15: 1179–1186
4. Cohen EEW, Lingen MW, Vokes EE (2004) The expanding role of systemic therapy in head and neck cancer. J Clin Oncol 22: 1743–1752
5. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KSC, Schultz CJ, Lee N, Fu KK, the Radiation Therapy Oncology Group 9501/Intergroup (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350: 1937–1944